Drug intelligence / Profile preview

hyoscine

Development stage
Unknown
Lead developer
Sparsha Pharma International
Modality
Small Molecules
Administration
Transdermal
01

Overview

HyloTouch Softip Patch is a transdermal delivery system containing the alkaloid **hyoscine** (also known as **scopolamine**), developed and marketed by **Sparsha Pharma International**. The product is indicated for the prevention of nausea and vomiting associated with **motion sickness**. The patch utilizes Sparsha's proprietary 'Softip' technology, which is designed to improve patient comfort and ensure consistent, sustained drug delivery through the skin. Hyoscine acts as a competitive antagonist at muscarinic acetylcholine receptors, particularly in the vestibular system and the vomiting center of the central nervous system, thereby inhibiting the cholinergic signaling that triggers motion-induced emesis.

Brand names
HyloTouch Softip PatchHyloTouch
Other names
scopolaminel-scopolaminehyoscine hydrobromide
02

Targets

M1 (Muscarinic acetylcholine receptor M1)CHRM3 (M3)HTR3A (5-hydroxytryptamine receptor 3A)CHRM5 (M5)CHRM2 (M2)CHRM4 (M4)

Beyond the preview

Go deeper on hyoscine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hyoscine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call